Tag Archives: Drug

Crisis Looms in Antibiotics as Drug Makers Go Bankrupt

At a time when germs are growing more resistant to common antibiotics, many companies that are developing new versions of the drugs are hemorrhaging money and going out of business, gravely undermining efforts to contain the spread of deadly, drug-resistant bacteria. Antibiotic start-ups like Achaogen and Aradigm have gone belly up in recent months, pharmaceutical… Read More »

Canada sours on its drug system just as Trump looks to import from it

Just as the Trump administration is planning to let states import prescription drugs from Canada, the United States’s northern neighbors have grown impatient with their own high drug prices. Canada is enmeshed in a drug pricing war. Canadians are paying among the highest prices in the world for drugs, prompting lawmakers to consider a major… Read More »

Global Blood’s sickle cell drug wins FDA approval, joining Novartis’ Adakveo

Dive Brief: The Food and Drug Administration on Monday approved Global Blood Therapeutics’ sickle cell drug voxelotor, completing a rapid review that took the regulator about 90 days. The accelerated OK is conditional on the biotech completing a study to confirm the rise in hemoglobin measured in trials so far yields clinical benefit. Global Blood… Read More »

World’s most expensive drug costs $US2m

Gene therapy drug Zolgensma has become the world’s most expensive drug, with the one-time treatment priced at $ US2.1255 million ($ A3 million). Swiss drugmaker Novartis has won US approval for its gene therapy Zolgensma for spinal muscular atrophy (SMA), the leading genetic cause of death in infants. Novartis executives defended the price, saying that… Read More »